Skip to main content
Richard Pollard, MD, Infectious Disease, Sacramento, CA

RichardByrdPollardMD

Infectious Disease Sacramento, CA

Professor, Internal Medicine, UC, Davis School of Medicine

Dr. Pollard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Pollard's full profile

Already have an account?

  • Office

    4150 V St
    PSSB G500
    Sacramento, CA 95817
    Phone+1 916-734-3815
    Fax+1 916-734-7766

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineResidency, Internal Medicine, 1973 - 1975
  • Ohio State University Hospital
    Ohio State University HospitalInternship, Internal Medicine, 1970 - 1971
  • University of Maryland School of Medicine
    University of Maryland School of MedicineClass of 1970

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1975 - 2026
  • TX State Medical License
    TX State Medical License 1978 - 2002
  • GA State Medical License
    GA State Medical License 1974 - 1979
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Grant Support

  • North-Central California-Center For AIDS ResearchNational Center For Research Resources2004–2007
  • Phase I Study To Evaluate Safety Of Dermavir, A HIV Vaccine, In HIV-I Subjects UNational Center For Research Resources2004
  • Immune Reconst W Growth Hormone In HIV Inf Subj W/ Incomplete CD4+ Lymphocyte RENational Center For Research Resources2004
  • HIV-1 Vaccines Designed To Induce Mucosal ImmunityNational Center For Research Resources2004
  • BAY 50-4798 Administered In Patients W/ HIV Infection On Haart Compared To PatieNational Center For Research Resources2004
  • Attenuated Strain Of Vaccinia Virus Administered To HIV Inf Indiv W/ ControlledNational Center For Research Resources2004
  • A Trial To Evaluate The Ability Of IL-2 To Enhance Hiv-Specific Immunity FollowNational Center For Research Resources2004
  • North-Central California-Center For AIDS ResearchNational Institute Of Allergy And Infectious Diseases2002–2003
  • Safety, Pharmacokinetics &Effects Of Calanolide On Surrogate MarkersNational Center For Research Resources2000–2002
  • Pharmacokinetic Study Of Nine Hydroxyurea Regimens In Combination With DDI &D4tNational Center For Research Resources2000–2002
  • Interactions &Efficacy Of Nevirapine, Abacavir And AmprenavirNational Center For Research Resources2000–2002
  • Gw433908 Versus Amprenavir In Subjects With HIV-1 InfectionNational Center For Research Resources2000–2002
  • ACTG 384--Protease Inhibitor &Non-Nucleoside Reverse Transcriptase InhibitorNational Center For Research Resources2000–2002
  • ACTG 328--Hiv/Immunogenicity Of Remune With Haart Or Haart &Il2National Center For Research Resources2000–2002
  • Highly Active Antiretroviral Therapy W/Wo Rhil 2 For HIV Positive PatientsNational Center For Research Resources1998–2002
  • Adult AIDS Clinical Trial UnitNational Institute Of Allergy And Infectious Diseases2000–2001
  • Clinical Center For Viral Activation Transfusion StudyDivision Of Blood Diseases And Resources1995–2000
  • Safety Of Recombinant Human Interleukin 12 By Subcutaneous Injection For HIVNational Center For Research Resources1998–1999
  • Women'S Health AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
  • Pharmacology AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
  • Outreach AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
  • Outcomes Committee AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
  • Neurology AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
  • Immunology And Immune Based Therapy AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
  • HIV Disease Research AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
  • Core--Advanced Technology LaboratoriesNational Institute Of Allergy And Infectious Diseases1996–1999
  • Complications Of HIV Disease AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
  • Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1992–1999
  • Multiple-Dose Safety, PK &Arv Interaction Of Oral Bms-180194 In AIDSNational Center For Research Resources1997
  • Multiple-Dose Safety, PK &Azt Interaction Of Oral Bms-180194 In AIDSNational Center For Research Resources1996
  • AIDS Clinical TrialsNational Institute Of Allergy And Infectious Diseases1994–1995
  • Adult AIDS Clinical ResearchNational Institute Of Allergy And Infectious Diseases1992–1995
  • Burn Injury Herpesviruses And ImmunityNational Institute Of General Medical Sciences1985–1987